First-line anti-EGFR agents (panitumumab or cetuximab) plus chemotherapy in patients with metastatic colorectal cancer: Onco-colon Turkey study subgroup analysis

Autor:	Isikdogan, A., Sakin, A., Tural, D., Cubukcu, E., Bozkurt, O., Harputluoglu, H., Kefeli, U., Alacacioglu, A., Geredeli, C., Cicin, I., Artac, M., Karabulut, B., Sendur, M., Bilir, C., Turk, H., YALÇIN, SIDDIKA SONGÜL, GÜMÜŞ, MAHMUT, Karadurmus, N., Arslan, C., Cevik, D., Dane, F., Cil, T.
Přispěvatelé:	KÖKER, İBRAHİM HAKKI
Rok vydání:	2022
Předmět:	Onco-colon Turkey study subgroup analysis- ANNALS OF ONCOLOGY cilt.33 2022 [Isikdogan A. Turk H. Bilir C. Sendur M. Karabulut B. Artac M. Cicin I. Geredeli C. Alacacioglu A. Kefeli U. et al. -First-line anti-EGFR agents (panitumumab or cetuximab) plus chemotherapy in patients with metastatic colorectal cancer]
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=od______9651::028cb7ccc65fb5b27dbc379fc3b274ad http://hdl.handle.net/20.500.12645/30868 Zobrazit plný text záznamu